The Europe Veterinary Dermatology Drugs Market would witness market growth of 7.8% CAGR during the forecast period (2021-2027).
The increase in the geographical spreading of parasites and the high risk of vector-borne infections outside conventional endemic areas are due to the changes in the ecology of parasite habitats. Moreover, the advent of foreign species in endemic areas, climate change, and increment in travel by companion animal owners have also boosted the demand for veterinary dermatology drugs market. This factor is expected to create lucrative growth opportunities for the players operating in the veterinary dermatology drugs market during the forecast period. Moreover, there has been a constant rise in emerging diseases like helminth parasites and protozoal parasitic diseases. Further, the growth of the veterinary dermatology drugs market would be boosted by the development of innovative methods like molecular diagnostics to detect and fight against these diseases.
Major market players are putting high investments to roll out the latest products, thereby creating new growth avenues in the market. For example, Elanco rolled out its first oral flea and tick products for cats in May 2021. The product is termed Credelio CAT (lotilaner) and it expands Elanco's product portfolio and assists it to get a competitive advantage in the market.
Europe is expected to remain the prominent region in the overall veterinary dermatology drugs market during the forecast period. The growth of the regional market would be boosted by the various dermatological associations in the European region which is boosting the awareness regarding skin disorders. For example, the European Society of Veterinary Dermatology is a non-profit organization that propels the development of veterinary dermatology across Europe and offers funding for both research activities as well as education programs like workshops.
The region was severely hit by the global pandemic; hence the regional market is negatively impacted by the complete or partial closure of manufacturing, packaging, and processing operation across different countries of the region. However, the manufacturing units of such companies are still operational and they are completely following the social distancing and other safety and hygiene norms formulated by the government. Hence, these factors are estimated to boost the growth of the regional veterinary dermatology drugs market during the forecast period.
The Germany market dominated the Europe Online Market by Country 2020, thereby, achieving a market value of $189.9 million by 2027. The UK market is exhibiting a CAGR of 7.5% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 9% during (2021 - 2027).
Based on Route of Administration, the market is segmented into Topical, Injectable and Oral. Based on Distribution Channel, the market is segmented into Retail, Hospital Pharmacies and Online. Based on Drug Indication, the market is segmented into Parasitic Infections, Allergic Infections and Other Indications. Based on Animal Type, the market is segmented into Companion Animal and Livestock Animal. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Veterinary Dermatology Drugs Market Size will Hit $13.6 Billion by 2027, at a CAGR of 8.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Elanco Animal Health, Inc., Zoetis, Inc., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Vetoquinol SA (Soparfin SCA), Virbac, Bioibérica, S.A.U., Bimeda, Inc., and Ceva Santé Animale.
Scope of the Study
Market Segments Covered in the Report:
By Route of Administration
By Distribution Channel
- Retail
- Hospital Pharmacies
- Online
By Drug Indication
- Parasitic Infections
- Allergic Infections
- Other Indications
By Animal Type
- Companion Animal
- Livestock Animal
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Merck Group
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Vetoquinol SA (Soparfin SCA)
- Virbac
- Bioibérica, S.A.U.
- Bimeda, Inc.
- Ceva Santé Animale
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Veterinary Dermatology Drugs Market, by Route of Administration
1.4.2 Europe Veterinary Dermatology Drugs Market, by Distribution Channel
1.4.3 Europe Veterinary Dermatology Drugs Market, by Drug Indication
1.4.4 Europe Veterinary Dermatology Drugs Market, by Animal Type
1.4.5 Europe Veterinary Dermatology Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Veterinary Dermatology Drugs Market by Route of Administration
3.1 Europe Topical Market by Country
3.2 Europe Injectable Market by Country
3.3 Europe Oral Market by Country
Chapter 4. Europe Veterinary Dermatology Drugs Market by Distribution Channel
4.1 Europe Retail Market by Country
4.2 Europe Hospital Pharmacies Market by Country
4.3 Europe Online Market by Country
Chapter 5. Europe Veterinary Dermatology Drugs Market by Drug Indication
5.1 Europe Parasitic Infections Market by Country
5.2 Europe Allergic Infections Market by Country
5.3 Europe Other Indications Market by Region
Chapter 6. Europe Veterinary Dermatology Drugs Market by Animal Type
6.1 Europe Companion Animal Market by Country
6.2 Europe Livestock Animal Market by Country
Chapter 7. Europe Veterinary Dermatology Drugs Market by Region
7.1 Germany Veterinary Dermatology Drugs Market
7.1.1 Germany Veterinary Dermatology Drugs Market by Route of Administration
7.1.2 Germany Veterinary Dermatology Drugs Market by Distribution Channel
7.1.3 Germany Veterinary Dermatology Drugs Market by Drug Indication
7.1.4 Germany Veterinary Dermatology Drugs Market by Animal Type
7.2 UK Veterinary Dermatology Drugs Market
7.2.1 UK Veterinary Dermatology Drugs Market by Route of Administration
7.2.2 UK Veterinary Dermatology Drugs Market by Distribution Channel
7.2.3 UK Veterinary Dermatology Drugs Market by Drug Indication
7.2.4 UK Veterinary Dermatology Drugs Market by Animal Type
7.3 France Veterinary Dermatology Drugs Market
7.3.1 France Veterinary Dermatology Drugs Market by Route of Administration
7.3.2 France Veterinary Dermatology Drugs Market by Distribution Channel
7.3.3 France Veterinary Dermatology Drugs Market by Drug Indication
7.3.4 France Veterinary Dermatology Drugs Market by Animal Type
7.4 Russia Veterinary Dermatology Drugs Market
7.4.1 Russia Veterinary Dermatology Drugs Market by Route of Administration
7.4.2 Russia Veterinary Dermatology Drugs Market by Distribution Channel
7.4.3 Russia Veterinary Dermatology Drugs Market by Drug Indication
7.4.4 Russia Veterinary Dermatology Drugs Market by Animal Type
7.5 Spain Veterinary Dermatology Drugs Market
7.5.1 Spain Veterinary Dermatology Drugs Market by Route of Administration
7.5.2 Spain Veterinary Dermatology Drugs Market by Distribution Channel
7.6 Spain Veterinary Dermatology Drugs Market by Drug Indication
7.6.1 Spain Veterinary Dermatology Drugs Market by Animal Type
7.7 Italy Veterinary Dermatology Drugs Market
7.7.1 Italy Veterinary Dermatology Drugs Market by Route of Administration
7.7.2 Italy Veterinary Dermatology Drugs Market by Distribution Channel
7.7.3 Italy Veterinary Dermatology Drugs Market by Drug Indication
7.7.4 Italy Veterinary Dermatology Drugs Market by Animal Type
7.8 Rest of Europe Veterinary Dermatology Drugs Market
7.8.1 Rest of Europe Veterinary Dermatology Drugs Market by Route of Administration
7.8.2 Rest of Europe Veterinary Dermatology Drugs Market by Distribution Channel
7.8.3 Rest of Europe Veterinary Dermatology Drugs Market by Drug Indication
7.8.4 Rest of Europe Veterinary Dermatology Drugs Market by Animal Type
Chapter 8. Company Profiles
8.1 Merck Group
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.2 Elanco Animal Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.5.2 Product Launches and product Expansions:
8.3 Zoetis, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trials:
8.4 Eli Lilly and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisitions and Mergers:
8.5 Boehringer Ingelheim International Gmbh
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.6 Vetoquinol SA (Soparfin SCA)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.6.3.2 Acquisitions and Mergers:
8.7 Virbac
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.8 Bioibérica, S.A.U.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Bimeda, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisitions and Mergers:
8.9.2.2 Product Launches and Product Expansions:
8.10. Ceva Santé Animale
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
TABLE 1 Asia Pacific Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 3 Asia Pacific Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 4 Asia Pacific Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 5 Asia Pacific Topical Market by Country, 2017 - 2020, USD Million
TABLE 6 Asia Pacific Topical Market by Country, 2021 - 2027, USD Million
TABLE 7 Asia Pacific Injectable Market by Country, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Injectable Market by Country, 2021 - 2027, USD Million
TABLE 9 Asia Pacific Oral Market by Country, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Oral Market by Country, 2021 - 2027, USD Million
TABLE 11 Asia Pacific Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 12 Asia Pacific Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 13 Asia Pacific Retail Market by Country, 2017 - 2020, USD Million
TABLE 14 Asia Pacific Retail Market by Country, 2021 - 2027, USD Million
TABLE 15 Asia Pacific Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 16 Asia Pacific Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 17 Asia Pacific Online Market by Country, 2017 - 2020, USD Million
TABLE 18 Asia Pacific Online Market by Country, 2021 - 2027, USD Million
TABLE 19 Asia Pacific Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 20 Asia Pacific Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 21 Asia Pacific Parasitic Infections Market by Region, 2017 - 2020, USD Million
TABLE 22 Asia Pacific Parasitic Infections Market by Region, 2021 - 2027, USD Million
TABLE 23 Asia Pacific Allergic Infections Market by Country, 2017 - 2020, USD Million
TABLE 24 Asia Pacific Allergic Infections Market by Country, 2021 - 2027, USD Million
TABLE 25 Asia Pacific Other Indications Market by Region, 2017 - 2020, USD Million
TABLE 26 Asia Pacific Other Indications Market by Region, 2021 - 2027, USD Million
TABLE 27 Asia Pacific Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 28 Asia Pacific Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 29 Asia Pacific Companion Animal Market by Country, 2017 - 2020, USD Million
TABLE 30 Asia Pacific Companion Animal Market by Country, 2021 - 2027, USD Million
TABLE 31 Asia Pacific Livestock Animal Market by Country, 2017 - 2020, USD Million
TABLE 32 Asia Pacific Livestock Animal Market by Country, 2021 - 2027, USD Million
TABLE 33 Asia Pacific Veterinary Dermatology Drugs Market by Region, 2017 - 2020, USD Million
TABLE 34 Asia Pacific Veterinary Dermatology Drugs Market by Region, 2021 - 2027, USD Million
TABLE 35 China Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 36 China Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 37 China Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 38 China Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 39 China Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 40 China Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 41 China Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 42 China Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 43 China Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 44 China Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 45 Japan Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 46 Japan Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 47 Japan Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 48 Japan Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 49 Japan Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 50 Japan Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 51 Japan Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 52 Japan Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 53 Japan Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 54 Japan Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 55 India Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 56 India Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 57 India Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 58 India Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 59 India Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 60 India Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 61 India Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 62 India Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 63 India Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 64 India Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 65 South Korea Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 66 South Korea Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 67 South Korea Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 68 South Korea Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 69 South Korea Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 70 South Korea Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 71 South Korea Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 72 South Korea Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 73 South Korea Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 74 South Korea Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 75 Singapore Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 76 Singapore Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 77 Singapore Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 78 Singapore Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 79 Singapore Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 80 Singapore Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 81 Singapore Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 82 Singapore Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 83 Singapore Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 84 Singapore Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 85 Malaysia Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 86 Malaysia Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 87 Malaysia Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 88 Malaysia Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 89 Malaysia Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 90 Malaysia Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 91 Malaysia Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 92 Malaysia Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 93 Malaysia Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 94 Malaysia Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 95 Rest of Asia Pacific Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 96 Rest of Asia Pacific Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 97 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 98 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 99 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 100 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 101 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 102 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 103 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 104 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 105 key Information – Merck Group
TABLE 106 Key information – Elanco Animal Health, Inc.
TABLE 107 Key Information – Zoetis, Inc.
TABLE 108 Key Information – Eli Lilly and Company
TABLE 109 Key Information – Boehringer Ingelheim International GmbH
TABLE 110 Key Information – Vetoquinol SA
TABLE 111 Key Information – Virbac
TABLE 112 Key Information – Bioibérica, S.A.U.
TABLE 113 Key Information – Bimeda, Inc.
TABLE 114 Key Information – Ceva Santé Animale
List of Figures
FIG 1 Methodology for the research
FIG 1 Recent strategies and developments: Bioibérica, S.A.U.
FIG 2 Recent strategies and developments: Bimeda, Inc.